Chirality and drugs used to treat psychiatric disorders.
作者信息
Baker Glen B, Prior Trevor I, Coutts Ronald T
出版信息
J Psychiatry Neurosci. 2002 Nov;27(6):401-3.
Abstract
摘要
相似文献
1
Chirality and drugs used to treat psychiatric disorders.
J Psychiatry Neurosci. 2002 Nov;27(6):401-3.
2
How do drugs for psychiatric disorders work?
Epidemiol Psychiatr Sci. 2018 Apr;27(2):141-142. doi: 10.1017/S204579601700066X. Epub 2017 Nov 9.
3
[Psychotropic medication in children and adolescents].
Rev Prat. 2014 Apr;64(4):525-9.
4
A parallel universe where psychiatry is like the rest of medicine.
Epidemiol Psychiatr Sci. 2018 Apr;27(2):143-145. doi: 10.1017/S2045796017000762. Epub 2017 Dec 4.
5
Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.
J Psychosoc Nurs Ment Health Serv. 2016 Jul 1;54(7):21-4. doi: 10.3928/02793695-20160616-09.
6
Psychiatric Drug Discovery and Development--SRI's Third Annual Conference.
IDrugs. 2005 Jun;8(6):475-8.
7
Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS.
Nat Rev Drug Discov. 2017 Jan;16(1):1-2. doi: 10.1038/nrd.2016.205. Epub 2016 Nov 4.
8
Neurosteroids and neuroactive drugs in mental disorders.
Life Sci. 2004 May 14;74(26):3181-97. doi: 10.1016/j.lfs.2003.12.002.
9
Drugs for psychiatric disorders.
Treat Guidel Med Lett. 2006 Jun;4(46):35-46.
10
Connectivity between mitochondrial functions and psychiatric disorders.
Psychiatry Clin Neurosci. 2011 Mar;65(2):130-41. doi: 10.1111/j.1440-1819.2010.02178.x.
引用本文的文献
1
Fundamental Clock of Biological Aging: Convergence of Molecular, Neurodegenerative, Cognitive and Psychiatric Pathways: Non-Equilibrium Thermodynamics Meet Psychology.
Int J Mol Sci. 2021 Dec 28;23(1):285. doi: 10.3390/ijms23010285.
2
d-glutamate and Gut Microbiota in Alzheimer's Disease.
Int J Mol Sci. 2020 Apr 11;21(8):2676. doi: 10.3390/ijms21082676.
3
Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.
Forensic Sci Med Pathol. 2011 Jun;7(2):162-84. doi: 10.1007/s12024-010-9188-3. Epub 2010 Nov 4.
本文引用的文献
1
Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugs.
Ann Med. 2002;34(7-8):537-43. doi: 10.1080/078538902321117742.
2
Stereochemistry: definitions and a note on nomenclature.
Hum Psychopharmacol. 2001 Dec;16(S2):S105-S107. doi: 10.1002/hup.334.
3
The enantiomer debate: current status and future directions.
Hum Psychopharmacol. 2001 Dec;16(S2):S101-S104. doi: 10.1002/hup.338.
4
Unmet needs in the pharmacological management of depression.
Hum Psychopharmacol. 2001 Dec;16(S2):S93-S99. doi: 10.1002/hup.337.
5
Enantiomeric antidepressant drugs should be considered on individual merit.
Hum Psychopharmacol. 2001 Dec;16(S2):S85-S92. doi: 10.1002/hup.336.
6
An introduction to enantiomers in psychopharmacology.
Hum Psychopharmacol. 2001 Dec;16(S2):S79-S84. doi: 10.1002/hup.335.
7
The therapeutic promise of single enantiomers: introduction.
Hum Psychopharmacol. 2001 Dec;16(S2):S73-S77. doi: 10.1002/hup.333.
8
Do single enantiomers have something special to offer?
Hum Psychopharmacol. 2001 Dec;16(S2):S67-S71. doi: 10.1002/hup.339.
9
Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
J Clin Psychiatry. 2002 Apr;63(4):331-6. doi: 10.4088/jcp.v63n0410.
10
Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care.
Int Clin Psychopharmacol. 2002 May;17(3):95-102. doi: 10.1097/00004850-200205000-00001.
Zotero 插件